Accreditation Statements

• MD:  This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS) through the joint providership of Des Moines University Medicine and Health Sciences (DMU) and the Iowa Medical Society. DMU is accredited by IMS to provide continuing me​​​​​​dical education for ph​​​​​​​y​​​​​​​sicians. DMU designates this live activity for a maximum of x.x AMA PRA Category 1 Credit(s)^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
• DO: Des Moines University Medicine and health Sciences (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this activity for a maximum of x.x AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
• Nurse: Des Moines University Medicine and Health Sciences is Iowa Board of Nursing approved provider #112. This live activity has been reviewed and approved for x.x continuing education contact hour(s). Nurses must attend the entire session to receive credit. Partial session credit is prohibited and will be forfeited.
• Other Health Professionals: This live activity is designated for x.x AMA PRA Category 1 Credit(s)^TM. 

EDUCATIONAL GRANTS

No ineligible company provided financial support for this continuing education activity.

DISCLOSURE

The planning committee member(s) and speaker(s) will disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). The determination of educational content and the selection of speakers is the responsibility of the activity director. 

Relevant to the content of this educational activity, the following individual(s) have no conflict(s) with ineligible companies to disclose.

• Todd Ajax. MD -Planning Committee Member
• Grace Fleming - Activity Director
• Mark Granner, MD - Speaker
• Christopher Groth, MD - Planning Committee Member
• Rahul Khanna, MD - Planning Committee Member
• Shivakrishna Kovi, MD - Planning Committee Member
• Rachel Marshall, MD - Speaker
• Nicole McMenamin - Activity Coordinator and Planning Committee Member
• Justin Sipla - Speaker
• Nicholas Wasko, MD, PhD - Planning Committee Member
• John Wright, MD - Planning Committee Member

Relevant to the content of this educational activity, the following individual(s) have conflict(s) with ineligible companies to disclose. All relevant financial relationships have been mitigated.

• Alicia Duyvejonck, DNP, AGNP-C, AQH - Speaker
  • Consultant: Lilly, Tonix - Advisory Board
  • Honoraria: Lilly, Impel, Lundbeck, AbbVie, Tonix
  • Speaker’s Bureau: Lilly, Abbvie, Lundbeck, Impel, Tonix
• Christine Gill, MD - Planning Committee Member
  • Consultant: TG Therapeutics Advisory Board
• James Howard, MD - Speaker
  • Consultant: Alexion AstraZeneca, Amgen, argenx, Biohaven Ltd, Biologix Pharma, CorEvitas, F. Hoffmann-LaRoche Ltd, Merck EMB Serono, NMD Pharma, Novartis,, Ra Pharmaceuticals, Regeneron Pharmaceuticals, Sanofi US, Toleranzia AB, UCB Bioscience, Zai Labs
  • Honoraria: AcademicCME, Alexion AstraZeneca, Amgen, argenx, Biohaven Ltd, Biologix Pharma, CorEvitas, F. Hoffman-LaRoche Ltd, Medscape CME, Immunovant, Merck EMB Serono, NMD Pharma, Novartis, PeerView CME, Physicians' Education Resource (PER) CME, PlatformQ CME, Ra Pharmaceuticals, Regeneron Pharmaceuticals, Sanofi US, Toleranzia AB, UCB Bioscience, Zai Labs
  • Research Support: Alexion AstraZeneca, argenx, Cartesian Therapeutics, Millennium Pharmaceuticals, National Institutes of Health, PCORI, RaPharmaceuticals, UCB Biosciences
  • Intends to discuss the off-label use of a commercial product or device and agrees to inform the learners before the presentation.
• Annie Killoran, MD - Speaker
  • Intends to discuss the off-label use of a commercial product or device and agrees to inform the learners before the presentation.
• Kamal Shouman - Speaker
  • Intends to discuss the off-label use of a commercial product or device and agrees to inform the learners before the presentation.

Disclaimer

The information provided at this activity is for continuing education purposes only. It is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University Medicine and Health Sciences.